Literature DB >> 19610592

A reactive ortho-quinone generated by tyrosinase-catalyzed oxidation of the skin depigmenting agent monobenzone: self-coupling and thiol-conjugation reactions and possible implications for melanocyte toxicity.

Paola Manini1, Alessandra Napolitano, Wiete Westerhof, Patrick A Riley, Marco d'Ischia.   

Abstract

Monobenzone (hydroquinone monobenzylether, 1) is a potent skin depigmenting agent that causes irreversible loss of epidermal melanocytes by way of a tyrosinase-dependent mechanism so far little understood. Herein, we show that 1 can be oxidized by mushroom tyrosinase to an unstable o-quinone (1-quinone) that has been characterized by comparison of its properties with those of a synthetic sample obtained by o-iodoxybenzoic acid-mediated oxidation of 1. Preparative scale oxidation of 1 with tyrosinase and catalytic l-DOPA, followed by reductive workup and acetylation, led to the isolation of two main products that were identified as the acetylated catechol derivative 4 and an unusual biphenyl-type dimer of 4, acetylated 5, arising evidently by coupling of 4 with 1-quinone. In the presence of l-cysteine or N-acetyl-l-cysteine, formation of 4 and 5 was inhibited, and the reaction led instead to monoadducts (6 or 9) and diadducts (7 and 8). A similar behavior was observed when the tyrosinase-promoted oxidation of 1 was carried out in the presence of sulfhydryl-containing peptides, such as reduced glutathione, or proteins, such as bovine serum albumin (BSA), as inferred by detection of adduct 9 by high pressure liquid chromatography-electrochemical detection (HPLC-ED) after acid hydrolysis. The generation and reaction chemistry of 1-quinone described in this article may bear relevance to the etiopathogenetic mechanisms of monobenzone-induced leukoderma as well as to the recently proposed haptenation hypothesis of vitiligo, a disabling pigmentary disorder characterized by irreversible melanocyte loss.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19610592     DOI: 10.1021/tx900018q

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  12 in total

1.  Enhanced bleaching treatment: opportunities for immune-assisted melanocyte suicide in vitiligo.

Authors:  Kirsten C Webb; Jonathan M Eby; Vidhya Hariharan; Claudia Hernandez; Rosalie M Luiten; I Caroline Le Poole
Journal:  Exp Dermatol       Date:  2014-07-10       Impact factor: 3.960

2.  Topical application of bleaching phenols; in-vivo studies and mechanism of action relevant to melanoma treatment.

Authors:  Vidhya Hariharan; Timothy Toole; Jared Klarquist; Jeffrey Mosenson; B Jack Longley; I Caroline Le Poole
Journal:  Melanoma Res       Date:  2011-04       Impact factor: 3.599

Review 3.  Immunomodulation of Melanoma by Chemo-Thermo-Immunotherapy Using Conjugates of Melanogenesis Substrate NPrCAP and Magnetite Nanoparticles: A Review.

Authors:  Yasuaki Tamura; Akira Ito; Kazumasa Wakamatsu; Takafumi Kamiya; Toshihiko Torigoe; Hiroyuki Honda; Toshiharu Yamashita; Hisashi Uhara; Shosuke Ito; Kowichi Jimbow
Journal:  Int J Mol Sci       Date:  2022-06-09       Impact factor: 6.208

4.  Effective melanoma immunotherapy in mice by the skin-depigmenting agent monobenzone and the adjuvants imiquimod and CpG.

Authors:  Jasper G van den Boorn; Debby Konijnenberg; Esther P M Tjin; Daisy I Picavet; Nico J Meeuwenoord; Dmitri V Filippov; J P Wietze van der Veen; Jan D Bos; Cornelis J M Melief; Rosalie M Luiten
Journal:  PLoS One       Date:  2010-05-13       Impact factor: 3.240

5.  UV photolysis of diclofenac in water; kinetics, degradation pathway and environmental aspects.

Authors:  Marin Kovacic; Daria Juretic Perisic; Martina Biosic; Hrvoje Kusic; Sandra Babic; Ana Loncaric Bozic
Journal:  Environ Sci Pollut Res Int       Date:  2016-04-13       Impact factor: 4.223

6.  Melanoma-Targeted Chemothermotherapy and In Situ Peptide Immunotherapy through HSP Production by Using Melanogenesis Substrate, NPrCAP, and Magnetite Nanoparticles.

Authors:  Kowichi Jimbow; Yasue Ishii-Osai; Shosuke Ito; Yasuaki Tamura; Akira Ito; Akihiro Yoneta; Takafumi Kamiya; Toshiharu Yamashita; Hiroyuki Honda; Kazumasa Wakamatsu; Katsutoshi Murase; Satoshi Nohara; Eiichi Nakayama; Takeo Hasegawa; Itsuo Yamamoto; Takeshi Kobayashi
Journal:  J Skin Cancer       Date:  2013-02-21

Review 7.  Biochemical Mechanism of Rhododendrol-Induced Leukoderma.

Authors:  Shosuke Ito; Kazumasa Wakamatsu
Journal:  Int J Mol Sci       Date:  2018-02-12       Impact factor: 5.923

8.  Mechanism of action of 4-substituted phenols to induce vitiligo and antimelanoma immunity.

Authors:  Arthur Kammeyer; Karin J Willemsen; Wouter Ouwerkerk; Walbert J Bakker; Danielle Ratsma; Sebas D Pronk; Nico P M Smit; Rosalie M Luiten
Journal:  Pigment Cell Melanoma Res       Date:  2019-03-18       Impact factor: 4.693

9.  Melanogenesis Inhibitor(s) from Phyla nodiflora Extract.

Authors:  Feng-Lin Yen; Moo-Chin Wang; Chan-Jung Liang; Horng-Huey Ko; Chiang-Wen Lee
Journal:  Evid Based Complement Alternat Med       Date:  2012-11-12       Impact factor: 2.629

10.  Norartocarpetin from a folk medicine Artocarpus communis plays a melanogenesis inhibitor without cytotoxicity in B16F10 cell and skin irritation in mice.

Authors:  Horng-Huey Ko; Yi-Ting Tsai; Ming-Hong Yen; Chun-Ching Lin; Chan-Jung Liang; Tsung-Han Yang; Chiang-Wen Lee; Feng-Lin Yen
Journal:  BMC Complement Altern Med       Date:  2013-12-10       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.